News - Generics


Current filters:


Popular Filters

1140 to 1164 of 1239 results

Australian PBS deferrals risk creating two-tier health system, drugmakers argue


Federal Cabinet’s decision to defer the listing of new medicines on the Pharmaceutical Benefits…


Russia’n firm Grumant invests $45 million in herbal APIs plant


Grumant, one of Russia’s largest manufacturers of pharmaceutical ingredients based on medicinal…

EuropeFinancialGenericsGrumantMarkets & Marketing

US Senate Judiciary Committee passes legislation to stop pay-for-delay patent settlements


US legislation to stop anticompetitive drug patent settlements, the bipartisan Bill S 27, Preserve Access…

GenericsLegalNorth AmericaPatentsPharmaceutical

Dr Reddy’s acquires Rx business in Russia and other CIS markets; reports 1st-qtr FY 2012 results


Generics company Dr Reddy’s Laboratories (NYSE: RDY), India’s second largest drugmaker, has…

Dr Reddy's LaboratoriesFinancialGenericsMergers & Acquisitions

US generics market poised for “stupendous” growth, says RNCOS


Backed by factors like patent expiration of drugs and aging population, the US generics market will expand…

DiabetesGenericsMarkets & MarketingNeurologicalNorth AmericaPatents

Merck & Co sets up China marketing JV with Simcere


US pharma giant Merck & Co (NYSE: MRK) has signed a framework agreement with leading Chinese drugmaker…

Asia-PacificCardio-vascularDiabetesGenericsMarkets & MarketingMerck & CoPharmaceuticalSimcere Pharmaceutical

Zydus Cadila 1st-qtr fiscal net profit jumps 15%


Indian drugmaker Zydus Cadila reported sales of 11.89 billion rupees ($175.2 million) for its fiscal…

FinancialGenericsZydus Cadila

Major changes at US FDA, with new posts and appointments


The world of FDA regulation is changing rapidly and, in an effort to keep current, US Food and Drug Administration…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

US Senators debut bipartisan bill to encourage states to use generic drugs In Medicaid program


In an effort to increase consumer flexibility and save taxpayer dollars, US Senators Scott Brown (Republican,…

GenericsHealthcareNorth AmericaPharmaceuticalPolitics

Par Pharma branded business faces setback, say Zacks analysts


US drugmaker Par Pharmaceuticals’ (NYSE: PRX) proprietary products division, Strativa Pharmaceuticals,…

FinancialGenericsOncologyPar PharmaceuticalsPharmaceuticalStrativa PharmaceuticalsZuplenz

API production in Russia: scarce but slowly developing


Over the past few years a trend toward slow development has been observed on the part of producers of…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Japan and China dominate Asian API market


The market for active pharmaceutical ingredients (APIs) is highest in the USA, followed by Europe and…

Asia-PacificGenericsMarkets & MarketingPharmaceutical

US generics market, worth $74 billion in 2009, set to grow at 10% CAGR


The US generics market has shown a solid growth during the past few years backed by factors, such as…

Gastro-intestinalsGenericsMarkets & MarketingNorth America

Sandoz expands strategic alliance with Nipro in Japan; Shionogi licenses drug to Ildong


Sandoz, a generics subsidiary of US drug major Novartis (NOVN: VX) has entered into a strategic alliance…

Asia-PacificGenericsIldong PharmaLicensingNovartisPharmaceuticalpirfenidoneSandozShionogi

First meeting of BRICS health ministers brings new leadership to global health


Universal access to medicines was a key topic of discussion at a meeting this week of health ministers…


Hikma takes stake in China’s Hubei Haosun to enhance API sourcing


Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has acquired…

GenericsHikma PharmaceuticalsHubei HaosunMergers & AcquisitionsOncology

Pfizer gains six months patent life for Lipitor on pediatric data; Bayer Yasmin patent scotched


US drugs behemoth Pfizer (NYSE: PFE) could extend the European patent term for its al-time blockbuster…


New date set for hearing of the Kenya Anti-Counterfeit court case


Hearings of the constitutional case challenging the implementation of the Kenya Anti-Counterfeit Act,…

GenericsLegalRest of the World

Government tenders for production of life-saving drugs in Russia


The Russian Ministry of Industry and Trade Ministry has announced a tender for the production of five…

GenericsMarkets & Marketing

Generic drugs changing the economics of treating chronically ill patients, US study finds


As the USA seeks to expand health care coverage to more citizens without adding burdensome costs, researchers…

GenericsHealthcareNorth AmericaPricing

Decrease in problematic pay-for-delay patent settlements in the EU, says Commission


The European Commission's second monitoring exercise of patent settlements in the pharmaceutical sector…


Shire sues Sandoz and Amneal for Vyvanse patent infringements


Ireland-headquartered drugmaker Shire (LSE: SHP) says it has filed law suits in the US District Court…

Amneal PharmaGenericsLegalNeurologicalNorth AmericaNovartisPatentsPharmaceuticalSandozShireVyvanse

1140 to 1164 of 1239 results

Back to top